OTO-201: Nonclinical assessment of a sustained-release ciprofloxacin hydrogel for the treatment of otitis media

Otology and Neurotology

Volumn 35, Issue 3, 2014, Pages 459-469

  Wang, Xiaobo ^a   Fernandez, Rayne ^a   Tsivkovskaia, Natalia ^a   Harrop Jones, Anne ^a   Hou, Huiying J ^a   Dellamary, Luis ^a   Dolan, David F ^b   Altschuler, Richard A ^b   Lebel, Carl ^a   Piu, Fabrice ^a  

^a Otonomy Inc   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Ciprofloxacin; Hydrogel; Otitis media; Sustained release

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN;

ANIMAL; ARTICLE; CHINCHILLA; DELAYED RELEASE FORMULATION; DISEASE MODEL; GUINEA PIG; HYDROGEL; OTITIS MEDIA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; CHINCHILLA; CIPROFLOXACIN; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; GUINEA PIGS; HYDROGELS; OTITIS MEDIA;

EID: 84894474499     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000261     Document Type: Article

References (40)

1. AAP-AAFP. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451-65.
2. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics 2013;131:e964-99.
3. Pelton SI, Leibovitz E. Recent advances in otitis media. Pediatr Infect Dis J 2009;28:S133-7.
4. Roland PS, Parry DA, Stroman DW. Microbiology of acute otitis media with tympanostomy tubes. Otolaryngol Head Neck Surg 2005;133:585-95.
5. Morpeth JF, Bent JP, Watson T. A comparison of cortisporin and ciprofloxacin otic drops as prophylaxis against post-tympanostomy otorrhea. Int J Pediatr Otorhinolaryngol 2001;61:99-104.
6. Nawasreh O, Al-Wedyan IA. Prophylactic ciprofloxacin drops after tympanostomy tube insertion. Saudi Med J 2004;25:38-40.
7. Giles W, Dohar J, Iverson K, Cockrum P, Hill F, Hill N. Ciprofloxacin/dexamethasone drops decrease the incidence of physician and patient outcomes of otorrhea after tube placement. Int J Pediatr Otorhinolaryngol 2007;71:747-56.
8. Piu F, Wang X, Fernandez R, et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurotol 2011;32:171-9.
9. Wang X, Dellamary L, Fernandez R, et al. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol Neurootol 2009;14:393-401.
10. Wang X, Dellamary L, Fernandez R, Ye Q, Lebel C, Piu F. Principles of inner ear sustained release following intratympanic administration. Laryngoscope 2011;121:385-91.
11. Lambert PR, Nguyen S, Maxwell KS, et al. A randomized, doubleblind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Meniere's disease. Otol Neurotol 2012;33: 1257-65.
12. Roland PS, Wall M. Ciprofloxacin 0.3%/dexamethasone 0.1% topical drops for the management of otic infections. Expert Opin Pharmacother 2008;9:3129-35.
13. Wall GM, Stroman DW, Roland PS, Dohar J. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. Pediatr infect Dis J 2009;28:141-4.
14. Drehobl M, Guerrero JL, Lacarte PR, Goldstein G, Mata FS, Luber S. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*. Curr Med Res Opin 2008;24:3531-42.
15. Miro N. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension. Otolaryngol Head Neck Surg 2000;123:617-23.
16. Salt AN. Pharmacokinetics of drug entry into cochlear fluids. Volta Rev 2006;105:277-98.
17. Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study. Antimicrob Agents Chemother 1999;43:1901-8.
18. Thornsberry C, Ogilvie PT, Holley HP Jr, Sahm DF. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob Agents Chemother 1999;43:2612-23.
19. Ambrose PG, Bhavnani SM, Rubino CM, et al. Pharmacokineticspharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Clin Infect Dis 2007;44:79-86.
20. Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 1999;58:29-36.
21. Bakaletz LO. Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention. Expert Rev Vaccines 2009; 8:1063-82.
22. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006;296:202-11.
23. Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001;111:2083-94.
24. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11:1034-43.
25. Giacometti A, Cirioni O, Ghiselli R, et al. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 2005;49:4042-5.
26. Qu Y, Daley AJ, Istivan TS, Rouch DA, Deighton MA. Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics. J Antimicrob Chemother. 2010;65:1405-11.
27. Oxley KS, Thomas JG, Ramadan HH. Effect of ototopical medications on tympanostomy tube biofilms. Laryngoscope 2007;117: 1819-24.
28. Housley L, Anderson T, Sontag N, Han SH, Britt DW, Anderson AJ. Pluronics' influence on pseudomonad biofilm and phenazine production. FEMS Microbiol Lett 2009;293:148-53.
29. Dogru S, Haholu A, Gungor A, et al. Histologic analysis of the effects of three different support materials within rat middle ear. Otolaryngol Head Neck Surg 2009;140:177-82.
30. Saber A, Laurell G, Bramer T, Edsman K, Engmer C, Ulfendahl M. Middle ear application of a sodium hyaluronate gel loaded with neomycin in a Guinea pig model. Ear Hear 2009;30:81-9.
31. Singh-Joy SD, McLain VC. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol 2008;27:93-128.
32. Russell PT, Church CA, Jinn TH, Kim DJ, John EO, Jung TT. Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells. Acta Otolaryngol 2001; 121:135-9.
33. Migirov L, Himmelfarb M. Methodology for studying the effects of topically applied ear drops on otoacoustic emissions in guinea pigs. J Laryngol Otol 2003;117:696-9.
34. Ikiz AO, Serbetcioglu B, Guneri EA, Sutay S, Ceryan K. Investigation of topical ciprofloxacin ototoxicity in guinea pigs. Acta Otolaryngol 1998;118:808-12.
35. Ichibangase T, Yamano T, Miyagi M, Nakagawa T, Morizono T. Ototoxicity of Povidone-Iodine applied to the middle ear cavity of guinea pigs. Int J Pediatr Otorhinolaryngol 2011;75:1078-81.
36. Mikulec AA, Hartsock JJ, Salt AN. Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures. Otol Neurotol 2008; 29:1020-6.
37. Force RW, Hart MC, Plummer SA, Powell DA, Nahata MC. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg 1995;121:880-4.
38. Heslop A, Lildholdt T, Gammelgaard N, Ovesen T. Topical ciprofloxacin is superior to topical saline and systemic antibiotics in the treatment of tympanostomy tube otorrhea in children: the results of a randomized clinical trial. Laryngoscope. 2010;120:2516-20.
39. Lous J, Ryborg CT, Thomsen JL. A systematic review of the effect of tympanostomy tubes in children with recurrent acute otitis media. Int J Pediatr Otorhinolaryngol. 2011;31.
40. Browning GG, Rovers MM, Williamson I, Lous J, Burton MJ. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 2010: CD001801.